Simon Erskine - Anatara Lifesciences Chief Officer
| ANR Stock | 0.06 0 1.72% |
Executive
Simon Erskine is Chief Officer of Anatara Lifesciences
| Phone | 61 4 3802 7172 |
| Web | https://anataralifesciences.com |
Anatara Lifesciences Management Efficiency
The company has return on total asset (ROA) of (0.5901) % which means that it has lost $0.5901 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.2679) %, meaning that it generated substantial loss on money invested by shareholders. Anatara Lifesciences' management efficiency ratios could be used to measure how well Anatara Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| LLB BCom | Collins Foods | N/A | |
| David Kelly | Collins Foods | N/A | |
| PMP MSc | Centaurus Metals | 45 | |
| MSc PMP | Centaurus Metals | 46 | |
| Adam Thatcher | Collins Foods | N/A | |
| Andrew Leyden | Collins Foods | N/A | |
| Tony Ark | Collins Foods | N/A | |
| Priyamvada Rasal | Collins Foods | N/A | |
| Julia Oliveira | Centaurus Metals | N/A | |
| Wayne Mausimm | Centaurus Metals | N/A | |
| Joanne Matthews | Collins Foods | N/A | |
| Hans Miete | Collins Foods | N/A | |
| Helen Moore | Collins Foods | N/A | |
| BA LLB | Collins Foods | N/A | |
| Nigel Williams | Collins Foods | N/A | |
| BEc BA | Collins Foods | 62 | |
| Roger MAusIMM | Centaurus Metals | N/A | |
| BTrngDev GradCertHR | Collins Foods | N/A | |
| David Kelley | Collins Foods | N/A | |
| David Timm | Collins Foods | N/A | |
Management Performance
| Return On Equity | -1.27 | |||
| Return On Asset | -0.59 |
Anatara Lifesciences Leadership Team
Elected by the shareholders, the Anatara Lifesciences' board of directors comprises two types of representatives: Anatara Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anatara. The board's role is to monitor Anatara Lifesciences' management team and ensure that shareholders' interests are well served. Anatara Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anatara Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| BSc EMBA, Chief Officer | ||
| Grad Sc, Commercial Manager | ||
| AGIA BCom, Company Sec | ||
| FACRRM FAICD, Ex Chairman | ||
| Jane Lowe, Managing Department | ||
| Simon Erskine, Chief Officer | ||
| FACID FACRRM, Executive Chairman |
Anatara Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Anatara Lifesciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.27 | |||
| Return On Asset | -0.59 | |||
| Operating Margin | 2.85 % | |||
| Current Valuation | 10.56 M | |||
| Shares Outstanding | 207.89 M | |||
| Shares Owned By Insiders | 29.97 % | |||
| Shares Owned By Institutions | 12.89 % | |||
| Price To Book | 8.68 X | |||
| Price To Sales | 6.31 X | |||
| Revenue | (123.18 K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.